CNN aims to put more emphasis on news and less on cable as it launches a new subscription streaming tier that will have more features for an audience that wants news first and a connection to ...

STARKVILLE, Miss.—Mississippi State’s Jordan Spencer is now the director of the university’s ACCESS Program and Specialized College Services, a new unit that expands MSU’s support to students with ...

Volkswagen, a company whose name translates to “people’s car,” is looking to become more people’s car with its Driver Access program. Aimed at making its vehicles drivable even for customers with ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Good programmers need to create code that efficiently solves problems, using various methods. A ...

Note: This story was updated May 13, 2025, to correct information about the company’s clinical trials. Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an ...

The Trump administration is reportedly weighing its options whether or not it will cut access to Naloxone, a medicine that can “rapidly reverse” an opioid overdose, according to the DEA. The federal ...

The first patient has been enrolled in an expanded access program (EAP) trial evaluating MN-166 (ibudilast), Medicinova’s oral anti-inflammatory drug, in people with amyotrophic lateral sclerosis (ALS ...

Stephen Dowd had been living homeless in Seattle for more than a year and a half, using fentanyl, when he was swept up in an Uber near Dick’s Drive-In in Uptown and driven to a treatment center in ...

The Supreme Court will hear oral arguments on Wednesday in a major challenge to the federal “E-rate program,” which subsidizes telephone and high-speed internet services in schools, libraries, rural ...

U.S. Urology Partners offers rBCG for NMIBC through an FDA-approved Expanded Access Program to address BCG shortages. The rBCG vaccine, developed with the Serum Institute of India, shows improved ...

Credit: ImmunityBio. Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe ...